BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2544289)

  • 1. Treatment of acute migraine with subcutaneous GR43175 in West Germany.
    Baar HA; Brand J; Doenicke A; Melchart D; Lüben V; Tryba M; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():83-7. PubMed ID: 2544289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine.
    Brion N; Bons J; Plas J; Bayliss EM; Advenier C
    Cephalalgia; 1989; 9 Suppl 9():79-82. PubMed ID: 2544288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early clinical experience with subcutaneous GR43175 in acute migraine: an overview.
    Tfelt-Hansen P; Brand J; Dano P; Doenicke A; Findley LJ; Iversen HK; Melchart D; Sahlender HM
    Cephalalgia; 1989; 9 Suppl 9():73-7. PubMed ID: 2544287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective improvement of symptoms in patients with acute migraine by GR43175 administered in dispersible tablets.
    Doenicke A; Melchart D; Bayliss EM
    Cephalalgia; 1989; 9 Suppl 9():89-92. PubMed ID: 2544290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine.
    Perrin VL; Färkkilä M; Goasguen J; Doenicke A; Brand J; Tfelt-Hansen P
    Cephalalgia; 1989; 9 Suppl 9():63-72. PubMed ID: 2544286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.
    Doenicke A; Brand J; Perrin VL
    Lancet; 1988 Jun; 1(8598):1309-11. PubMed ID: 2897560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being.
    Dahlöf C; Edwards C; Toth A
    Cephalalgia; 1992 Aug; 12(4):214-20. PubMed ID: 1326404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early studies with the novel 5-HT 1-like agonist GR43175 in healthy volunteers.
    Fowler PA; Thomas M; Lacey LF; Andrew P; Dallas FA
    Cephalalgia; 1989; 9 Suppl 9():57-62. PubMed ID: 2544285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group.
    Ensink FB
    J Neurol; 1991; 238 Suppl 1():S66-9. PubMed ID: 1646291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
    Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
    N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine.
    Fullerton T; Gengo FM
    Ann Pharmacother; 1992 Jun; 26(6):800-8. PubMed ID: 1319244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
    Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
    Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Dechant KL; Clissold SP
    Drugs; 1992 May; 43(5):776-98. PubMed ID: 1379152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute migraine with subcutaneous sumatriptan.
    Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
    JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sumatriptan in the treatment of acute migraine attacks].
    Diener HC
    Internist (Berl); 1993 Jan; 34(1):63-6; discussion 66. PubMed ID: 8382666
    [No Abstract]   [Full Text] [Related]  

  • 17. Sumatriptan for migraine.
    Med Lett Drugs Ther; 1992 Oct; 34(880):91-3. PubMed ID: 1326077
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.
    Humphrey PP; Feniuk W; Perren MJ; Connor HE; Oxford AW
    Cephalalgia; 1989; 9 Suppl 9():23-33. PubMed ID: 2544280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sumatriptan and its use in treatment of migraine and cluster headaches].
    Prusiński A
    Neurol Neurochir Pol; 1992; Suppl 2():28-48. PubMed ID: 1337766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.